Michel Ghilezan

21st Century Oncology (United States) — United States

Medicine · Health Sciences

14h-index1.3kcitations78works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(54), Advanced Radiotherapy Techniques(50), Prostate Cancer Treatment and Research(37), Breast Cancer Treatment Studies(8), Advanced X-ray and CT Imaging(6)

Publications78 total

Rates of rectal toxicity in patients treated with high dose rate brachytherapy as monotherapy compared to dose-escalated external beam radiation therapy for localized prostate cancer
Radiotherapy and Oncology·2020· 12 cited
Low and Intermediate Risk Prostate Cancer Treated with Single Fraction 19 Gy High Dose Rate Brachytherapy as Monotherapy: Outcomes Comparison to Multi-Fraction Regimens
Brachytherapy·2016· 2 citedOpen Access
Adaptive Dose Recalculation for Prostate Cancer in the Era of Online IGRT IMRT: How Close Is the Planned Radiation Dose to the Delivered Dose?
International Journal of Radiation Oncology*Biology*Physics·2015Open Access
Accelerated partial breast irradiation (APBI): A less toxic breast cancer treatment technique underutilized in the Hispanic population.
Journal of Clinical Oncology·2015
High-dose-rate brachytherapy as monotherapy for prostate cancer
Brachytherapy·2014· 100 citedOpen Access
State of the Art Review High-dose-rate brachytherapy as monotherapy for prostate cancer
2014
Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients
Brachytherapy·2013· 24 cited
An age-corrected matched-pair study of erectile function in patients treated with adaptive intensity modulated radiation therapy (IMRT) versus high-dose-rate brachytherapy (HDR) in prostate cancer.
Journal of Clinical Oncology·2012
Contributors
Elsevier eBooks·2012
High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity Data
International Journal of Radiation Oncology*Biology*Physics·2011· 91 cited
Acute and Chronic Toxicity Analysis of Dose-Escalated 3-D Conformal Radiotherapy (3DCRT), IMRT, and Hypofractionated Image-Guided Radiotherapy (IGRT)
International Journal of Radiation Oncology*Biology*Physics·2011Open Access
Acute and Chronic Toxicity Profiles Associated with Three High-Dose-Rate Interstitial Brachytherapy Monotherapy Fractionation Schedules for Localized Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2011
Long-term Outcome Analysis for Low/Intermediate Risk Prostate Cancer Patients Treated with Permanent Interstitial or High-dose-rate Brachytherapy
International Journal of Radiation Oncology*Biology*Physics·2011
Dosimetric Effect of Intrafraction Motion and Residual Setup Error for Image-Guided Hypofractionated Prostate Radiotherapy
International Journal of Radiation Oncology*Biology*Physics·2011
Intrafraction Variation during Image Guided Hypofractionated Radiotherapy of the Prostate: Patient and Treatment Determinants
International Journal of Radiation Oncology*Biology*Physics·2011
WE‐A‐BRB‐04: Real‐Time Catheter Tracking for HDR Prostate Implant Using an Electromagnetic 3D Guidance Device
Medical Physics·2011
Prognostic Significance of Neuroendocrine Differentiation in Patients With Gleason Score 8–10 Prostate Cancer Treated With Primary Radiotherapy
International Journal of Radiation Oncology*Biology*Physics·2011· 31 cited
1020 poster HOW BIOLOGICALLY EFFECTIVE DOSE (BED) LEVEL IMPACT LONG-TERM OUTCOMES IN INTERMEDIATE-RISK PROSTATE CANCER PATIENTS TREATED WITH HIGH-DOSE-RATE BRACHYTHERAPY
Radiotherapy and Oncology·2011
1028 poster IS THERE A BENEFIT OF HORMONAL THERAPY FOR PATIENTS WITH HIGH RISK PROSTATE CANCER IN THE ERA OF DOSE-ESCALATED IMAGE-GUIDED RADIATION THERAPY
Radiotherapy and Oncology·2011
618 poster FOUR-YEAR RESULTS USING BALLOON BASED BRACHYTHER-APY TO DELIVER APBI WITH A TWO-DAY DOSE FRACTIONATION SCHEDULE
Radiotherapy and Oncology·2011
page 1 of 4Next →

Frequent Co-authors

Alvaro A. Martinez(40), Gary Gustafson(25), Larry L. Kestin(22), Frank A. Vicini(21), Di Yan(12), Daniel Krauss(11), Evelyn Sebastian(10), Hong Ye(8), D. Brabbins(8), Peter Y. Chen(6), C. Mitchell(6), Michelle Wallace(5), Amy Limbacher(5), Michelle Wallace(5), D. Jeffrey Demanes(4), Lionel Schour(4), J. Vito Antonucci(4), Sean S. Park(4), M. Wallace(4), K. Marvin(4)